Experienced Investor
The Share Centre’s top purchased funds for July
Andy Parsons, head of investment research at The Share Centre, rounds up the most popular funds on their platform last month – and examines what this could mean for investors.
The table below outlines July’s top purchased funds from The Share Centre
| Position | Fund |
| 1 | CF Woodford Equity Income |
| 2 | Fundsmith Equity |
| 3 | Vanguard FTSE All Share Index |
| 4 | L&G UK Index |
| 5 | F&C Navigator Boutiques |
| 6 | Aviva Property |
| 7 | Aberdeen MM Constellation |
| 8 | AXA Framlington Biotech |
| 9 | Old Mutual UK Mid-Cap |
| 10 | Polar Capital Healthcare Opportunities |
“The CF Woodford Equity Income fund is, as ever, an extremely popular choice for investors. Being both strong and perceived as defensively aligned, investors can have the peace of mind and assurance of a tried and trusted investment approach that has served Neil well throughout his distinguished investment career.”
“As a fund investing in equities on a global basis, the Fundsmith Equity Income fund is managed by the highly acclaimed founder of the business Terry Smith. With the number of holdings generally being between 20 -30 stocks, the underlying portfolio clearly depicts the managers conviction in the highly concentrated portfolio of global names in which he invests.
“The third and fourth most popular funds reignite the debate around passive vs active, as two funds that focus on replicating performance of the FTSE All-Share take their place – namely the Vanguard FTSE All Share Index fund and L&G UK Index.
“The fifth most popular fund was the F&C Navigator Boutiques fund, which seeks to achieve capital growth through investment in other collective or closed ended arrangements (also known as a fund of funds)
“The Aviva Property fund demonstrates investor appetite for an asset class that provides real portfolio diversification. The fund can be considered a true bricks & mortar fund; albeit the manager has the flexibility to invest in REITs should he deem it appropriate.
“The seventh most popular fund was another of fund proposition, namely the Aberdeen Multi Manager Constellation Income fund.
“One of two funds within the top 10 that had a sectorial bias, The AXA Framlington Biotech fund has a goal to provide long-term capital appreciation by investing principally in equity securities of biotechnology, genomics and medical companies worldwide.
“The Old Mutual UK Mid-Cap fund is a firm favourite with investors as it seeks to provide capital growth from investing primarily in a portfolio of medium sized UK companies. Driven by a combination of both bottom up and top down analysis, the portfolio will comprise of high conviction ideas.
“The final fund is the second sector specific offering, namely the Polar Capital Healthcare Opportunities fund. Whilst advances in medical and healthcare technology continue at a rapid pace, the offering will provide investors with not only exposure to the sector, but also significant geographical exposure to the US given the dominance of this market.”
